Tuesday, 21 January 2020 14.00 - 15.30 h
At the beginning of March, the WHO published a draft document entitled "Guidelines on Submission of Documentation for a multisource (Generic) Finished Pharmaceutical Product: Quality Part". The document provides recommendations on the submission of quality information for APIs and finished medicinal products with regard to national authorisation procedures for generic medicinal products. The basis for this is the modular structure of the CTD according to ICH M4Q which has been completely taken over by the WHO guideline.
The scope of this guideline encompasses generic medicinal products containing APIs which have been previously approved through a finished product by a regulatory authority which is a member of the ICH or an ICH observer. The guideline doesn't apply to biological, biotechnological and herbal APIs.
There are several scenarios for generic medicinal products regarding diverse API manufacturers, medicinal product strengths, containers, dosage forms, etc, like for example:
The guideline provides concrete recommendation on how to submit information within the CTD structure.
The document ends with an appendix about conducting and assessing comparative dissolution profiles.
The guideline can be commented until 25 April 2013.